Citing safety risks of “unusually high magnitude,” a U.S. advisory panel has explained why it recommended limiting publication of two bird flu research papers in late December.
Citing safety risks of “unusually high magnitude,” a U.S. advisory panel has explained why it recommended limiting publication of two bird flu research papers in late December.